Viral Disease (DBCOND0045704)

Identifiers

Synonyms
Viral Diseases / Virus Diseases / Virus Disease / Viral disease / Viral infection, unspecified / Viral infection / Infection viral / Viral disease (disorder) / Viral infection NOS / Viral infection of unspecified site

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05470907
Registry for Hemoperfusion of Covid-19 ICU PatientsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00023023
Study of Transfusion-Transmitted InfectionsNo drug interventionsNot AvailableNot Availablecompleted
NCT04403061
Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of OutcomeNo drug interventionsNot AvailableNot Availablecompleted
NCT04535167
First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.treatment1completed
NCT01037712
In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovirtreatment4terminated
NCT00359268
Identification of Viruses Associated With Diseases of Unknown CauseNo drug interventionsNot AvailableNot Availableterminated
NCT03336086
Effect of Weight Reduction on ImmunityNo drug interventionsother3completed
NCT05797246
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)treatment2recruiting
NCT05074953
Post-COVID-19 Monitoring in Routine Health Insurance DataNo drug interventionsNot AvailableNot Availablecompleted
NCT05875961
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in AdultsNo drug interventionsprevention1active_not_recruiting
NCT04633603
LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare SystemNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00001164
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal VolunteersNo drug interventionsNot AvailableNot Availablecompleted
NCT04346264
CoVid-19 - Infection and Antibody Formation in the Viennese PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT04644484
A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safetyprevention3completed
NCT01553279
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)prevention3completed
NCT04476979
Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19treatment2completed
NCT01991587
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in AdultsNo drug interventionsprevention1 / 2completed
NCT02831751
Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adultsprevention2completed
NCT00980447
Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young AdultsNo drug interventionsprevention2completed
NCT02012998
Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXAprevention3completed
NCT02447705
Replacement of Lamivudine by Telbivudine to Improve Renal Functiontreatment2 / 3completed
NCT05284097
Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Studyprevention2active_not_recruiting
NCT01021397
Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and ChildrenNo drug interventionsprevention1completed
NCT01991561
Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.prevention2completed
NCT03640728
The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver FailureNot AvailableNot Availablerecruiting
NCT03192371
A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Childrenprevention4withdrawn
NCT04046978
Modelling the Interaction Between Synthetic Model Immunogens and the Induced B and T Cell Repertoires.No drug interventionsbasic_scienceNot Availablewithdrawn
NCT01839188
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)prevention3completed
NCT01791556
Clinic-based ART Diagnostic EvaluationNo drug interventionshealth_services_researchNot Availablecompleted
NCT05277285
STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Caretreatment2recruiting
NCT02236052
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly PopulationNo drug interventionsprevention2completed
NCT01062659
Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) PatientsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00734175
Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine VaccineNo drug interventionsprevention1completed
NCT01839175
Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccinationprevention3completed
NCT03110770
VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and AdolescentsNo drug interventionsprevention2completed
NCT04710199
Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)treatment2completed
NCT03487549
Cantharidin and Occlusion in Verruca Epitheliumtreatment2completed
NCT05376124
Clinical Characteristics, Natural Outcome and Treatment Optimization of RefractoryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02022163
Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.No drug interventionsprevention1completed
NCT03119025
Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-InfectionNo drug interventionstreatment1 / 2completed
NCT06113757
Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT00722774
Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus VaccineNo drug interventionsprevention1completed
NCT00948220
Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis Cbasic_science4completed
NCT00366782
Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and AdultsNo drug interventionsprevention1completed
NCT04382131
Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)No drug interventionstreatmentNot Availableunknown_status
NCT01587131
DNA-based Influenza Vaccine in the ElderlyNo drug interventionsprevention1completed
NCT06149494
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionNo drug interventionstreatment2recruiting
NCT01107262
Avian Influenza Studies In LebanonNo drug interventionsNot AvailableNot Availablecompleted
NCT04367740
ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT01244867
Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza VaccineNo drug interventionsprevention2completed
NCT01337167
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)prevention3completed
NCT00448604
Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsNo drug interventionsNot AvailableNot Availablecompleted
NCT04398004
Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Earlyprevention2completed
NCT06366672
Evaluating the Human Immune Response to the JYNNEOS Vaccinebasic_science0recruiting
NCT02991872
A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese ChildrenNo drug interventionsprevention4completed
NCT03321968
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy AdultsNo drug interventionsother3completed
NCT04062669
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adultsprevention1completed
NCT03739112
Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderlyprevention3completed
NCT04398043
SARS-CoV 2 in Personal Protective EquipmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT02613403
Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)treatment2terminated
NCT01055990
Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 PatientsNo drug interventionstreatment2unknown_status
NCT00815464
A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis BNo drug interventionstreatmentNot Availableunknown_status
NCT00110279
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)No drug interventionsprevention1completed
NCT05321433
Tobacco Use and the Risk of COVID-19 and Adverse OutcomesNo drug interventionsNot AvailableNot Availablecompleted
NCT03301051
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in AdultsNo drug interventionsprevention3completed
NCT04412551
Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19No drug interventionsNot AvailableNot Availablecompleted
NCT02593851
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infectiontreatment1terminated
NCT00219453
Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-ContaminationNo drug interventionsprevention1completed
NCT04441047
Universal Anti-Viral Vaccine for Healthy Elderly AdultsNo drug interventionsprevention1 / 2completed
NCT00984945
Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy AdultsNo drug interventionsprevention1completed
NCT02469298
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenzatreatment2completed
NCT04124198
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell CarcinomatreatmentNot Availablerecruiting
NCT05606198
Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD)No drug interventionsNot AvailableNot Availablecompleted
NCT02768805
Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adultsprevention2completed
NCT01842997
Safety of H1N1 Influenza Vaccination in Pregnant WomenNo drug interventionsprevention4completed
NCT04074928
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjectsprevention3completed
NCT00343278
Pharmacokinetic Study Of Valaciclovir Hydrochloride Tabletstreatment4completed
NCT02548078
A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Childrenprevention2completed
NCT03392207
Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)No drug interventionsNot AvailableNot Availablecompleted
NCT00380237
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)No drug interventionsprevention1completed
NCT01340937
A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)prevention3completed
NCT05619770
Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human SubjectsNo drug interventionstreatment1active_not_recruiting
NCT05874713
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in AdultsNo drug interventionsprevention2active_not_recruiting
NCT04822818
EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19treatment3completed
NCT02545517
A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.prevention3completed
NCT00641017
Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus VaccineNo drug interventionsprevention1completed
NCT00921934
Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of ShinglesNo drug interventionsNot AvailableNot Availablecompleted
NCT04376034
Convalescent Plasma Collection and Treatment in Pediatrics and AdultsNo drug interventionstreatment3recruiting
NCT02233816
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in AdultsNo drug interventionsprevention2completed
NCT04322396
Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19treatment2terminated
NCT01480258
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)prevention3completed
NCT03294135
The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults VaccineNo drug interventionsprevention4completed
NCT00516035
Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adultsprevention1completed
NCT01341639
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)prevention3completed
NCT05422326
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or UnprimedNo drug interventionsprevention2completed
NCT00921726
Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adultstreatment1completed
NCT04357366
suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)prevention2completed
NCT02630082
Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruNo drug interventionsNot AvailableNot Availablecompleted
NCT02927431
Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenzatreatment2terminated
NCT03776994
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle VaccineNo drug interventionsprevention1unknown_status
NCT04758962
A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy AdultsNo drug interventionsprevention1completed
NCT00749580
A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI RegimentreatmentNot Availablecompleted
NCT01562444
Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination SchedulesNo drug interventionsprevention4completed
NCT01163240
Epidemiological Study in Children and Adolescents With Chronic Hepatitis BNo drug interventionsNot AvailableNot Availablecompleted
NCT04769167
Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and DiabetesNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT04414267
Bacillus Calmette-guérin Vaccination to Prevent COVID-19prevention4completed
NCT04380701
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adultstreatment1 / 2completed
NCT01289301
Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplanttreatment4unknown_status
NCT02485301
A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in AdultsNo drug interventionsprevention2completed
NCT00975572
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and OlderNo drug interventionsprevention2completed
NCT00347672
Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsNo drug interventionsprevention1completed
NCT04772469
Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in MenNo drug interventionspreventionNot Availablecompleted
NCT00488046
Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsNo drug interventionsprevention1completed
NCT04339712
Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunctiontreatment2completed
NCT00308412
Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy InfantsNo drug interventionsprevention1completed
NCT00853255
Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adultsprevention1completed
NCT06396624
Effects of Photobiomodulation on the Innate Immune System of Neonates and Infants With BronchiolitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04636320
Prevalence of Myocardial Scars on CMR After COVID-19 InfectionNo drug interventionsdiagnosticNot Availablecompleted
NCT03294473
Centralized Reminder Recall - Flu RCT2No drug interventionshealth_services_researchNot Availablecompleted
NCT05307991
Integrating Enhanced HIV PrEP Into a STI Clinic in LilongweNo drug interventionsNot AvailableNot Availablecompleted
NCT04365101
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19treatment1 / 2unknown_status
NCT04627623
Prevalence and Risk Factors of COVID-19 in the Upper Silesian AgglomerationNo drug interventionsNot AvailableNot Availableunknown_status
NCT01183611
The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonatesprevention3completed
NCT04403100
Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"treatment3unknown_status
NCT00005936
Collection of Liver Tissue for Virologic StudiesNo drug interventionsNot AvailableNot Availablecompleted
NCT04377724
Spread and Course of COVID-19 InfectionsNo drug interventionsNot AvailableNot Availablecompleted
NCT04409873
Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)supportive_care2terminated
NCT03192072
A Rapid Test for Acute Respiratory IllnessNo drug interventionsNot AvailableNot Availablecompleted